Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia

Advances in Pharmacology

Volumn 77, Issue , 2016, Pages 361-431

  Possomato Vieira, J S ^a   Khalil, R A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytokines; Endothelin; Endothelium; Growth factors; Hypertension; Hypoxia; Nitric oxide; Oxidative stress; Placental ischemia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; AUTOANTIBODY; CD135 ANTIGEN; ENDOGLIN; ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; HYPOXIA INDUCIBLE FACTOR; INTEGRIN; INTERLEUKIN DERIVATIVE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PLACENTAL GROWTH FACTOR; PROSTACYCLIN; THROMBOXANE A2; TUMOR NECROSIS FACTOR; VASCULOTROPIN; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN A;

ANGIOGENESIS; CELL INVASION; DEMOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; GENETIC RISK; HEREDITY; HUMAN; IMMUNE RESPONSE; ISCHEMIA; MATERNAL CARE; MATERNAL HYPERTENSION; NONHUMAN; PLACENTA DISORDER; PLACENTAL ISCHEMIA; PREECLAMPSIA; REPRODUCTION; RISK FACTOR; TROPHOBLAST; ANIMAL; HYPOXIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; HYPOXIA; ISCHEMIA; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84994137745     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2016.04.008     Document Type: Chapter

References (272)

1. Abdalvand, A., Morton, J.S., Bourque, S.L., Quon, A.L., Davidge, S.T., Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Hypertension 61 (2013), 488–493.
2. Adekola, H., Romero, R., Chaemsaithong, P., Korzeniewski, S.J., Dong, Z., Yeo, L., et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. The Journal of Maternal-Fetal & Neonatal Medicine 28 (2015), 1621–1632.
3. Agarwal, R., Loganath, A., Roy, A.C., Wong, Y.C., Ng, S.C., Expression profiles of interleukin-15 in early and late gestational human placenta and in pre-eclamptic placenta. Molecular Human Reproduction 7 (2001), 97–101.
4. Agunanne, E.E., Uddin, M.N., Horvat, D., Puschett, J.B., Contribution of angiogenic factors in a rat model of pre-eclampsia. American Journal of Nephrology 32 (2010), 332–339.
5. Ahmad, S., Ahmed, A., Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circulation Research 95 (2004), 884–891.
6. Akehurst, C., Small, H.Y., Sharafetdinova, L., Forrest, R., Beattie, W., Brown, C.E., et al. Differential expression of microRNA-206 and its target genes in preeclampsia. Journal of Hypertension 33 (2015), 2068–2074.
7. Akhilesh, M., Mahalingam, V., Nalliah, S., Ali, R.M., Ganesalingam, M., Haleagrahara, N., Hypoxia-inducible factor-1 alpha as a predictive marker in pre-eclampsia. Biomedical Reports 1 (2013), 257–258.
8. Alexander, B.T., Cockrell, K.L., Massey, M.B., Bennett, W.A., Granger, J.P., Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. American Journal of Hypertension 15 (2002), 170–175.
9. Alexander, B.T., Kassab, S.E., Miller, M.T., Abram, S.R., Reckelhoff, J.F., Bennett, W.A., et al. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37 (2001), 1191–1195.
10. Alexander, B.T., Llinas, M.T., Kruckeberg, W.C., Granger, J.P., L-Arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 43 (2004), 832–836.
11. Alexander, B.T., Miller, M.T., Kassab, S., Novak, J., Reckelhoff, J.F., Kruckeberg, W.C., et al. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 33 (1999), 435–439.
12. Alexander, B.T., Rinewalt, A.N., Cockrell, K.L., Massey, M.B., Bennett, W.A., Granger, J.P., Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37 (2001), 485–489.
13. Ali, S.M., Khalil, R.A., Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opinion on Therapeutic Targets 19 (2015), 1495–1515.
14. Alpoim, P.N., Gomes, K.B., Pinheiro Mde, B., Godoi, L.C., Jardim, L.L., Muniz, L.G., et al. Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia. Nitric Oxide 42 (2014), 19–23.
15. Amaral, L.M., Cornelius, D.C., Harmon, A., Moseley, J., Martin, J.N. Jr., LaMarca, B., 17-Hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension 65 (2015), 225–231.
16. Amaral, L.M., Pinheiro, L.C., Guimaraes, D.A., Palei, A.C., Sertorio, J.T., Portella, R.L., et al. Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia. Journal of Cellular and Molecular Medicine 17 (2013), 1300–1307.
17. Amraoui, F., Spijkers, L., Hassani Lahsinoui, H., Vogt, L., van der Post, J., Peters, S., et al. SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice. PLoS One, 9, 2014, e91897.
18. Anton, L., Merrill, D.C., Neves, L.A., Stovall, K., Gallagher, P.E., Diz, D.I., et al. Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 51 (2008), 1066–1072.
19. Anton, L., Olarerin-George, A.O., Hogenesch, J.B., Elovitz, M.A., Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia. PLoS One, 10, 2015, e0122707.
20. Bai, K., Wang, K., Li, X., Wang, J., Zhang, J., Song, L., et al. Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation. Acta Biochimica et Biophysica Sinica Shanghai 45 (2013), 749–755.
21. Baig, S., Kothandaraman, N., Manikandan, J., Rong, L., Ee, K.H., Hill, J., et al. Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia. Clinical Proteomics, 11, 2014, 40.
22. Bakker, W.W., Henning, R.H., van Son, W.J., van Pampus, M.G., Aarnoudse, J.G., Niezen-Koning, K.E., et al. Vascular contraction and preeclampsia: Downregulation of the angiotensin receptor 1 by hemopexin in vitro. Hypertension 53 (2009), 959–964.
23. Bates, D.O., An unexpected tail of VEGF and PlGF in pre-eclampsia. Biochemical Society Transactions 39 (2011), 1576–1582.
24. Bdolah, Y., Lam, C., Rajakumar, A., Shivalingappa, V., Mutter, W., Sachs, B.P., et al. Twin pregnancy and the risk of preeclampsia: Bigger placenta or relative ischemia?. American Journal of Obstetrics and Gynecology 198:428 (2008), e421–e426.
25. Ben Ali Gannoun, M., Zitouni, H., Raguema, N., Maleh, W., Gris, J.C., Almawi, W., et al. Association of common eNOS/NOS3 polymorphisms with preeclampsia in Tunisian Arabs. Gene 569 (2015), 303–307.
26. Bhavina, K., Radhika, J., Pandian, S.S., VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity. BioMed Research International, 2014, 2014, 982159.
27. Bian, Z., Shixia, C., Duan, T., First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia. PLoS One, 10, 2015, e0124684.
28. Bobek, G., Surmon, L., Mirabito, K.M., Makris, A., Hennessy, A., Placental regulation of inflammation and hypoxia after TNF-alpha infusion in mice. American Journal of Reproductive Immunology 74 (2015), 407–418.
29. Boyd, H.A., Tahir, H., Wohlfahrt, J., Melbye, M., Associations of personal and family preeclampsia history with the risk of early-, intermediate- and late-onset preeclampsia. American Journal of Epidemiology 178 (2013), 1611–1619.
30. Brandao, A.H., Felix, L.R., Patricio Edo, C., Leite, H.V., Cabral, A.C., Difference of endothelial function during pregnancies as a method to predict preeclampsia. Archives of Gynecology and Obstetrics 290 (2014), 471–477.
31. Brennan, L.J., Morton, J.S., Davidge, S.T., Vascular dysfunction in preeclampsia. Microcirculation 21 (2014), 4–14.
32. Burwick, R.M., Feinberg, B.B., Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta 34 (2013), 201–203.
33. Cakmak, M., Yilmaz, H., Baglar, E., Darcin, T., Inan, O., Aktas, A., et al. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Clinical and Experimental Hypertension 38:2 (2016), 137–142.
34. Canbakan, B., Keven, K., Tutkak, H., Danisman, N., Ergun, I., Nergizoglu, G., Circulating endothelial cells in preeclampsia. Journal of Human Hypertension 21 (2007), 558–563.
35. Celik, H., Avci, B., Isik, Y., Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia. Journal of Obstetrics and Gynaecology 33 (2013), 355–358.
36. Chambers, J.C., Fusi, L., Malik, I.S., Haskard, D.O., De Swiet, M., Kooner, J.S., Association of maternal endothelial dysfunction with preeclampsia. JAMA 285 (2001), 1607–1612.
37. Charnock-Jones, D.S., Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia. Journal of Reproductive Immunology 114 (2016), 81–85.
38. Chen, Q., Lau, S., Tong, M., Wei, J., Shen, F., Zhao, J., et al. Serum uric acid may not be involved in the development of preeclampsia. Journal of Human Hypertension 30 (2016), 136–140.
39. Chinnathambi, V., Blesson, C.S., Vincent, K.L., Saade, G.R., Hankins, G.D., Yallampalli, C., et al. Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries. Hypertension 64 (2014), 405–414.
40. Choi, S.Y., Yun, J., Lee, O.J., Han, H.S., Yeo, M.K., Lee, M.A., et al. MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta 34 (2013), 799–804.
41. Cindrova-Davies, T., Sanders, D.A., Burton, G.J., Charnock-Jones, D.S., Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovascular Research 89 (2011), 671–679.
42. Cohen, J.M., Kramer, M.S., Platt, R.W., Basso, O., Evans, R.W., Kahn, S.R., The association between maternal antioxidant levels in midpregnancy and preeclampsia. American Journal of Obstetrics and Gynecology 213 (2015), 695.e1–695.e13.
43. Coleman, H.A., Tare, M., Parkington, H.C., Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clinical and Experimental Pharmacology & Physiology 31 (2004), 641–649.
44. Conrad, K.P., Gandley, R.E., Ogawa, T., Nakanishi, S., Danielson, L.A., Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. The American Journal of Physiology 276 (1999), F767–F776.
45. Conrad, K.P., Kerchner, L.J., Mosher, M.D., Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. The American Journal of Physiology 277 (1999), F48–F57.
46. Cornelius, D.C., Amaral, L.M., Harmon, A., Wallace, K., Thomas, A.J., Campbell, N., et al. An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 309 (2015), R884–R891.
47. Cornelius, D.C., Hogg, J.P., Scott, J., Wallace, K., Herse, F., Moseley, J., et al. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62 (2013), 1068–1073.
48. Crews, J.K., Herrington, J.N., Granger, J.P., Khalil, R.A., Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35 (2000), 367–372.
49. Cross, C.E., Tolba, M.F., Rondelli, C.M., Xu, M., Abdel-Rahman, S.Z., Oxidative stress alters miRNA and gene expression profiles in villous first trimester trophoblasts. BioMed Research International, 2015, 2015, 257090.
50. Cui, X.L., Brockman, D., Campos, B., Myatt, L., Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: Involvement in preeclampsia. Placenta 27 (2006), 422–431.
51. Cui, Y., Wang, W., Dong, N., Lou, J., Srinivasan, D.K., Cheng, W., et al. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature 484 (2012), 246–250.
52. Davis, J.R., Giardina, J.B., Green, G.M., Alexander, B.T., Granger, J.P., Khalil, R.A., Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 282 (2002), R390–R399.
53. Deng, C.L., Ling, S.T., Liu, X.Q., Zhao, Y.J., Lv, Y.F., Decreased expression of matrix metalloproteinase-1 in the maternal umbilical serum, trophoblasts and decidua leads to preeclampsia. Experimental and Therapeutic Medicine 9 (2015), 992–998.
54. Doridot, L., Passet, B., Mehats, C., Rigourd, V., Barbaux, S., Ducat, A., et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 61 (2013), 662–668.
55. Dotsch, J., Hogen, N., Nyul, Z., Hanze, J., Knerr, I., Kirschbaum, M., et al. Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation. European Journal of Obstetrics, Gynecology, and Reproductive Biology 97 (2001), 163–167.
56. Echeverri, I., Ortega-Avila, J.G., Mosquera, M., Castillo, A., Jimenez, E., Suarez-Ortegon, M.F., et al. Relationship between maternal and newborn endothelial function and oxidative stress. American Journal of Human Biology 27 (2015), 822–831.
57. Ehsanipoor, R.M., Fortson, W., Fitzmaurice, L.E., Liao, W.X., Wing, D.A., Chen, D.B., et al. Nitric oxide and carbon monoxide production and metabolism in preeclampsia. Reproductive Sciences 20 (2013), 542–548.
58. Eleuterio, N.M., Palei, A.C., Rangel Machado, J.S., Tanus-Santos, J.E., Cavalli, R.C., Sandrim, V.C., Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies. Clinica Chimica Acta 423 (2013), 112–115.
59. Eleuterio, N.M., Palei, A.C., Rangel Machado, J.S., Tanus-Santos, J.E., Cavalli, R.C., Sandrim, V.C., Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant. Pregnancy Hypertension 5 (2015), 205–208.
60. Eremina, V., Jefferson, J.A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., et al. VEGF inhibition and renal thrombotic microangiopathy. The New England Journal of Medicine 358 (2008), 1129–1136.
61. Esplin, M.S., Fausett, M.B., Fraser, A., Kerber, R., Mineau, G., Carrillo, J., et al. Paternal and maternal components of the predisposition to preeclampsia. The New England Journal of Medicine 344 (2001), 867–872.
62. Fan, X., Rai, A., Kambham, N., Sung, J.F., Singh, N., Petitt, M., et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. The Journal of Clinical Investigation 124 (2014), 4941–4952.
63. Faupel-Badger, J.M., McElrath, T.F., Lauria, M., Houghton, L.C., Lim, K.H., Parry, S., et al. Maternal circulating angiogenic factors in twin and singleton pregnancies. American Journal of Obstetrics and Gynecology 212:636 (2015), e631–e638.
64. Fei, X., Hongxiang, Z., Qi, C., Daozhen, C., Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 and tHcy in pre-eclampsia. Advances in Clinical and Experimental Medicine 21 (2012), 573–579.
65. Feletou, M., Vanhoutte, P.M., EDHF: An update. Clinical Science (London, England) 117 (2009), 139–155.
66. Fernandez-Patron, C., Zouki, C., Whittal, R., Chan, J.S., Davidge, S.T., Filep, J.G., Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]. The FASEB Journal 15 (2001), 2230–2240.
67. Fiore, G., Florio, P., Micheli, L., Nencini, C., Rossi, M., Cerretani, D., et al. Endothelin-1 triggers placental oxidative stress pathways: Putative role in preeclampsia. The Journal of Clinical Endocrinology and Metabolism 90 (2005), 4205–4210.
68. Founds, S.A., Conley, Y.P., Lyons-Weiler, J.F., Jeyabalan, A., Hogge, W.A., Conrad, K.P., Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30 (2009), 15–24.
69. Fulep, E.E., Vedernikov, Y.P., Saade, G.R., Garfield, R.E., The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats. American Journal of Obstetrics and Gynecology 185 (2001), 638–642.
70. Furchgott, R.F., Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980), 373–376.
71. Gant, N.F., Daley, G.L., Chand, S., Whalley, P.J., MacDonald, P.C., A study of angiotensin II pressor response throughout primigravid pregnancy. The Journal of Clinical Investigation 52 (1973), 2682–2689.
72. Genc, H., Uzun, H., Benian, A., Simsek, G., Gelisgen, R., Madazli, R., et al. Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk. Archives of Gynecology and Obstetrics 284 (2011), 1367–1373.
73. George, E.M., Granger, J.P., Endothelin: Key mediator of hypertension in preeclampsia. American Journal of Hypertension 24 (2011), 964–969.
74. George, E.M., Palei, A.C., Dent, E.A., Granger, J.P., Sildenafil attenuates placental ischemia-induced hypertension. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 305 (2013), R397–R403.
75. Gilbert, J.S., Babcock, S.A., Granger, J.P., Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50 (2007), 1142–1147.
76. Gilbert, J.S., Gilbert, S.A., Arany, M., Granger, J.P., Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53 (2009), 399–403.
77. Gillis, E.E., Williams, J.M., Garrett, M.R., Mooney, J.N., Sasser, J.M., The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 309 (2015), R62–R70.
78. Gokina, N.I., Kuzina, O.Y., Vance, A.M., Augmented EDHF signaling in rat uteroplacental vasculature during late pregnancy. American Journal of Physiology. Heart and Circulatory Physiology 299 (2010), H1642–H1652.
79. Gomaa, M.F., Naguib, A.H., Swedan, K.H., Abdellatif, S.S., Serum tumor necrosis factor-alpha level and uterine artery Doppler indices at 11-13 weeks’ gestation for preeclampsia screening in low-risk pregnancies: A prospective observational study. Journal of Reproductive Immunology 109 (2015), 31–35.
80. Goulopoulou, S., Hannan, J.L., Matsumoto, T., Webb, R.C., Pregnancy reduces RhoA/Rho kinase and protein kinase C signaling pathways downstream of thromboxane receptor activation in the rat uterine artery. American Journal of Physiology. Heart and Circulatory Physiology 302 (2012), H2477–H2488.
81. Guimaraes, M.F., Brandao, A.H., Rezende, C.A., Cabral, A.C., Brum, A.P., Leite, H.V., et al. Assessment of endothelial function in pregnant women with preeclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery. Archives of Gynecology and Obstetrics 290 (2014), 441–447.
82. Gutkowska, J., Granger, J.P., Lamarca, B.B., Danalache, B.A., Wang, D., Jankowski, M., Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: Effect of tumor necrosis factor blockade. Journal of Hypertension 29 (2011), 1203–1212.
83. Hagedorn, K.A., Cooke, C.L., Falck, J.R., Mitchell, B.F., Davidge, S.T., Regulation of vascular tone during pregnancy: A novel role for the pregnane X receptor. Hypertension 49 (2007), 328–333.
84. Hall, D., Gebhardt, S., Theron, G., Grove, D., Pre-eclampsia and gestational hypertension are less common in HIV infected women. Pregnancy Hypertension 4 (2014), 91–96.
85. Hamai, Y., Fujii, T., Yamashita, T., Nishina, H., Kozuma, S., Mikami, Y., et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. American Journal of Reproductive Immunology 38 (1997), 89–93.
86. Hammond, S., Mathewson, A.M., Baker, P.N., Mayhew, T.M., Dunn, W.R., Gap junctions and hydrogen peroxide are involved in endothelium-derived hyperpolarising responses to bradykinin in omental arteries and veins isolated from pregnant women. European Journal of Pharmacology 668 (2011), 225–232.
87. He, H., Venema, V.J., Gu, X., Venema, R.C., Marrero, M.B., Caldwell, R.B., Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. The Journal of Biological Chemistry 274 (1999), 25130–25135.
88. Hefler, L.A., Reyes, C.A., O'Brien, W.E., Gregg, A.R., Perinatal development of endothelial nitric oxide synthase-deficient mice. Biology of Reproduction 64 (2001), 666–673.
89. Herraiz, I., Simon, E., Gomez-Arriaga, P.I., Martinez-Moratalla, J.M., Garcia-Burguillo, A., Jimenez, E.A., et al. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: An approach for clinical integration. International Journal of Molecular Sciences 16 (2015), 19009–19026.
90. Hiby, S.E., Walker, J.J., O'Shaughnessy, K.M., Redman, C.W., Carrington, M., Trowsdale, J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. The Journal of Experimental Medicine 200 (2004), 957–965.
91. Holwerda, K.M., Burke, S.D., Faas, M.M., Zsengeller, Z., Stillman, I.E., Kang, P.M., et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. Journal of the American Society of Nephrology 25 (2014), 717–725.
92. Hu, X.Q., Xiao, D., Zhu, R., Huang, X., Yang, S., Wilson, S., et al. Pregnancy upregulates large-conductance Ca(2 +)-activated K(+) channel activity and attenuates myogenic tone in uterine arteries. Hypertension 58 (2011), 1132–1139.
93. Hunter, A., Aitkenhead, M., Caldwell, C., McCracken, G., Wilson, D., McClure, N., Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36 (2000), 965–969.
94. Iriyama, T., Wang, W., Parchim, N.F., Song, A., Blackwell, S.C., Sibai, B.M., et al. Hypoxia-independent upregulation of placental hypoxia inducible factor-1alpha gene expression contributes to the pathogenesis of preeclampsia. Hypertension 65 (2015), 1307–1315.
95. Iwaki, T., Yamamoto, K., Matsuura, T., Sugimura, M., Kobayashi, T., Kanayama, N., Alteration of integrins under hypoxic stress in early placenta and choriocarcinoma cell line BeWo. Gynecologic and Obstetric Investigation 57 (2004), 196–203.
96. Jain, A., Schneider, H., Aliyev, E., Soydemir, F., Baumann, M., Surbek, D., et al. Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response. Laboratory Investigation 94 (2014), 873–880.
97. Jardim, L.L., Rios, D.R., Perucci, L.O., de Sousa, L.P., Gomes, K.B., Dusse, L.M., Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?. Clinica Chimica Acta 447 (2015), 34–38.
98. Javadian, P., Salmanian, B., Javadi-Paydar, M., Shamshirsaz, A.A., Ejtemaei Mehr, S., Gharedaghi, M.H., et al. Effect of morphine on the reduced uteroplacental perfusion model of pre-eclampsia in rats. European Journal of Obstetrics, Gynecology, and Reproductive Biology 168 (2013), 161–166.
99. Jiang, Z., Zou, Y., Ge, Z., Zuo, Q., Huang, S.Y., Sun, L., A role of sFlt-1 in oxidative stress and apoptosis in human and mouse pre-eclamptic trophoblasts. Biology of Reproduction, 93, 2015, 73.
100. Johnson, A.C., Tremble, S.M., Chan, S.L., Moseley, J., LaMarca, B., Nagle, K.J., et al. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia. PLoS One, 9, 2014, e113670.
101. Kakigano, A., Mimura, K., Kanagawa, T., Nakayama, M., Kanayama, T., Fujita, S., et al. Imbalance of angiogenic factors and avascular edematous cystic villi in a trisomy 13 pregnancy: A case report. Placenta 34 (2013), 628–630.
102. Kanagal, D.V., Rajesh, A., Rao, K., Devi, U.H., Shetty, H., Kumari, S., et al. Levels of serum calcium and magnesium in pre-eclamptic and normal pregnancy: A study from coastal India. Journal of Clinical and Diagnostic Research 8 (2014), OC01–OC04.
103. Karakus, S., Bozoklu Akkar, O., Yildiz, C., Sancakdar, E., Cetin, M., Cetin, A., Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls. Archives of Gynecology and Obstetrics 293:2 (2016), 351–359.
104. Kemse, N.G., Kale, A.A., Joshi, S.R., A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS One, 9, 2014, e111902.
105. Kenny, L.C., Baker, P.N., Kendall, D.A., Randall, M.D., Dunn, W.R., Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clinical Science (London, England) 103 (2002), 67–73.
106. Khalil, R.A., Crews, J.K., Novak, J., Kassab, S., Granger, J.P., Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31 (1998), 1065–1069.
107. Khalil, R.A., Granger, J.P., Vascular mechanisms of increased arterial pressure in preeclampsia: Lessons from animal models. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 283 (2002), R29–R45.
108. Kim, Y.G., Suga, S.I., Kang, D.H., Jefferson, J.A., Mazzali, M., Gordon, K.L., et al. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney International 58 (2000), 2390–2399.
109. Knock, G.A., Poston, L., Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. American Journal of Obstetrics and Gynecology 175 (1996), 1668–1674.
110. Kourembanas, S., McQuillan, L.P., Leung, G.K., Faller, D.V., Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. The Journal of Clinical Investigation 92 (1993), 99–104.
111. Krauss, T., Pauer, H.U., Augustin, H.G., Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertension in Pregnancy 23 (2004), 101–111.
112. Kriston, T., Venuto, R.C., Baylis, C., Losonczy, G., Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats. The American Journal of Physiology 276 (1999), R831–R837.
113. Lain, K.Y., Roberts, J.M., Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287 (2002), 3183–3186.
114. Lamarca, B., Brewer, J., Wallace, K., IL-6-induced pathophysiology during pre-eclampsia: Potential therapeutic role for magnesium sulfate?. International Journal of Interferon, Cytokine and Mediator Research 2011 (2011), 59–64.
115. LaMarca, B.B., Cockrell, K., Sullivan, E., Bennett, W., Granger, J.P., Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46 (2005), 82–86.
116. LaMarca, B., Parrish, M., Ray, L.F., Murphy, S.R., Roberts, L., Glover, P., et al. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: Role of endothelin-1. Hypertension 54 (2009), 905–909.
117. LaMarca, B., Speed, J., Fournier, L., Babcock, S.A., Berry, H., Cockrell, K., et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: Effect of tumor necrosis factor-alpha blockade. Hypertension 52 (2008), 1161–1167.
118. LaMarca, B., Wallukat, G., Llinas, M., Herse, F., Dechend, R., Granger, J.P., Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 52 (2008), 1168–1172.
119. Lamminpaa, R., Vehvilainen-Julkunen, K., Gissler, M., Heinonen, S., Preeclampsia complicated by advanced maternal age: A registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy and Childbirth, 12, 2012, 47.
120. Leik, C.E., Walsh, S.W., Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 44 (2004), 72–77.
121. Leonardo, D.P., Albuquerque, D.M., Lanaro, C., Baptista, L.C., Cecatti, J.G., Surita, F.G., et al. Association of nitric oxide synthase and matrix metalloprotease single nucleotide polymorphisms with preeclampsia and its complications. PLoS One, 10, 2015, e0136693.
122. Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. The New England Journal of Medicine 355 (2006), 992–1005.
123. Lewis, D.F., Canzoneri, B.J., Gu, Y., Zhao, S., Wang, Y., Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. American Journal of Reproductive Immunology 64 (2010), 376–383.
124. Li, H., Ge, Q., Guo, L., Lu, Z., Maternal plasma miRNAs expression in preeclamptic pregnancies. BioMed Research International, 2013, 2013, 970265.
125. Li, W., Mata, K.M., Mazzuca, M.Q., Khalil, R.A., Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Biochemical Pharmacology 89 (2014), 370–385.
126. Li, Q., Pan, Z., Wang, X., Gao, Z., Ren, C., Yang, W., miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia. Biochemical and Biophysical Research Communications 453 (2014), 57–63.
127. Lillegard, K.E., Johnson, A.C., Lojovich, S.J., Bauer, A.J., Marsh, H.C., Gilbert, J.S., et al. Complement activation is critical for placental ischemia-induced hypertension in the rat. Molecular Immunology 56 (2013), 91–97.
128. Liu, Y., Zhao, Y., Yu, A., Zhao, B., Gao, Y., Niu, H., Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: A meta-analysis based on 20 studies. Archives of Gynecology and Obstetrics 292 (2015), 507–518.
129. Llinas, M.T., Alexander, B.T., Seedek, M., Abram, S.R., Crell, A., Granger, J.P., Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. American Journal of Hypertension 15 (2002), 793–797.
130. Lockwood, C.J., Yen, C.F., Basar, M., Kayisli, U.A., Martel, M., Buhimschi, I., et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. The American Journal of Pathology 172 (2008), 1571–1579.
131. Losonczy, G., Singh, J.P., Schoenl, M., Mucha, I., Venuto, R.C., Pregnancy enhances the pressor response to thromboxane analogues in rabbits. The American Journal of Physiology 269 (1995), R720–R725.
132. Luft, F.C., Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule. Nephrology, Dialysis, Transplantation 21 (2006), 3052–3054.
133. Luksha, L., Nisell, H., Kublickiene, K., The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 286 (2004), R1102–R1109.
134. Luksha, L., Nisell, H., Luksha, N., Kublickas, M., Hultenby, K., Kublickiene, K., Endothelium-derived hyperpolarizing factor in preeclampsia: Heterogeneous contribution, mechanisms, and morphological prerequisites. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294 (2008), R510–R519.
135. Luque, A., Farwati, A., Crovetto, F., Crispi, F., Figueras, F., Gratacos, E., et al. Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Scientific Reports, 4, 2014, 4882.
136. Magee, L.A., Pels, A., Helewa, M., Rey, E., von Dadelszen, P., Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension 4 (2014), 105–145.
137. Majed, B.H., Khalil, R.A., Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacological Reviews 64 (2012), 540–582.
138. Mandala, M., Gokina, N., Barron, C., Osol, G., Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats. Journal of Vascular Research 49 (2012), 43–49.
139. March, M.I., Geahchan, C., Wenger, J., Raghuraman, N., Berg, A., Haddow, H., et al. Circulating angiogenic factors and the risk of adverse outcomes among Haitian women with preeclampsia. PLoS One, 10, 2015, e0126815.
140. Masoura, S., Kalogiannidis, I., Makedou, K., Theodoridis, T., Koiou, K., Gerou, S., et al. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: A case-control study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 175 (2014), 119–123.
141. Masuda, Y., Shimizu, A., Mori, T., Ishiwata, T., Kitamura, H., Ohashi, R., et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. The American Journal of Pathology 159 (2001), 599–608.
142. Matias, M.L., Romao, M., Weel, I.C., Ribeiro, V.R., Nunes, P.R., Borges, V.T., et al. Endogenous and uric acid-induced activation of NLRP3 inflammasome in pregnant women with preeclampsia. PLoS One, 10, 2015, e0129095.
143. Matsubara, K., Matsubara, Y., Hyodo, S., Katayama, T., Ito, M., Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. The Journal of Obstetrics and Gynaecology Research 36 (2010), 239–247.
144. Maynard, S., Epstein, F.H., Karumanchi, S.A., Preeclampsia and angiogenic imbalance. Annual Review of Medicine 59 (2008), 61–78.
145. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. The Journal of Clinical Investigation 111 (2003), 649–658.
146. Mazzuca, M.Q., Dang, Y., Khalil, R.A., Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca(2)(+)]i in mesenteric microvessels of pregnant rats. British Journal of Pharmacology 169 (2013), 1335–1351.
147. Mazzuca, M.Q., Khalil, R.A., Vascular endothelin receptor type B: Structure, function and dysregulation in vascular disease. Biochemical Pharmacology 84 (2012), 147–162.
148. Mazzuca, M.Q., Li, W., Reslan, O.M., Yu, P., Mata, K.M., Khalil, R.A., Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy. Hypertension 64 (2014), 632–643.
149. McBride, C.A., Bernstein, I.M., Badger, G.J., Horbar, J.D., Soll, R.F., The effect of maternal hypertension on mortality in infants 22, 29 weeks gestation. Pregnancy Hypertension 5 (2015), 362–366.
150. McDonald, S.D., Lutsiv, O., Dzaja, N., Duley, L., A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. International Journal of Gynaecology and Obstetrics 118 (2012), 90–96.
151. McMaster, M.T., Zhou, Y., Fisher, S.J., Abnormal placentation and the syndrome of preeclampsia. Seminars in Nephrology 24 (2004), 540–547.
152. Mills, J.L., DerSimonian, R., Raymond, E., Morrow, J.D., Roberts, L.J. 2nd, Clemens, J.D., et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: A multicenter prospective study. JAMA 282 (1999), 356–362.
153. Mistry, H.D., Kurlak, L.O., Broughton Pipkin, F., The placental renin-angiotensin system and oxidative stress in pre-eclampsia. Placenta 34 (2013), 182–186.
154. Mitchell, B.M., Cook, L.G., Danchuk, S., Puschett, J.B., Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension. American Journal of Hypertension 20 (2007), 1297–1304.
155. Molvarec, A., Czegle, I., Szijarto, J., Rigo, J. Jr., Increased circulating interleukin-17 levels in preeclampsia. Journal of Reproductive Immunology 112 (2015), 53–57.
156. Montagnana, M., Lippi, G., Albiero, A., Scevarolli, S., Salvagno, G.L., Franchi, M., et al. Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. Journal of Clinical Laboratory Analysis 23 (2009), 88–92.
157. Morawska, E., Kaczmarek, M.M., Blitek, A., Regulation of prostacyclin synthase expression and prostacyclin content in the pig endometrium. Theriogenology 78 (2012), 2071–2086.
158. Moreno-Eutimio, M.A., Tovar-Rodriguez, J.M., Vargas-Avila, K., Nieto-Velazquez, N.G., Frias-De-Leon, M.G., Sierra-Martinez, M., et al. Increased serum levels of inflammatory mediators and low frequency of regulatory T cells in the peripheral blood of preeclamptic Mexican women. BioMed Research International, 2014, 2014, 413249.
159. Morris, R., Spencer, S.K., Kyle, P.B., Williams, J.M., Harris, A., Owens, M.Y., et al. Hypertension in an animal model of HELLP syndrome is associated with activation of endothelin 1. Reproductive Sciences 23 (2015), 42–50.
160. Morton, J.S., Davidge, S.T., Arterial endothelium-derived hyperpolarization: Potential role in pregnancy adaptations and complications. Journal of Cardiovascular Pharmacology 61 (2013), 197–203.
161. Motta, C., Grosso, C., Zanuzzi, C., Molinero, D., Picco, N., Bellingeri, R., et al. Effect of sildenafil on pre-eclampsia-like mouse model induced by L-NAME. Reproduction in Domestic Animals 50 (2015), 611–616.
162. Murphy, S.R., Cockrell, K., Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: Role of angiotensin II. Physiological Reports, 3(2), 2015 pii: e12310.
163. Murphy, S.R., LaMarca, B.B., Cockrell, K., Granger, J.P., Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55 (2010), 394–398.
164. Myatt, L., Webster, R.P., Vascular biology of preeclampsia. Journal of Thrombosis and Haemostasis 7 (2009), 375–384.
165. Naiker, S., Naidoo, S., Naicker, T., Gathiram, P., Nadar, A., Moodley, J., Immunolocalisation and endothelin-1 values in pre-eclampsia: An immunocytochemical study. Journal of Obstetrics and Gynaecology 21 (2001), 39–45.
166. Nakamura, M., Sekizawa, A., Purwosunu, Y., Okazaki, S., Farina, A., Wibowo, N., et al. Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. Prenatal Diagnosis 29 (2009), 691–696.
167. Nascimento, R.A., Mendes, G., Possomato-Vieira, J.S., Goncalves-Rizzi, V.H., Kushima, H., Delella, F.K., et al. Metalloproteinase inhibition protects against reductions in circulating adrenomedullin during lead-induced acute hypertension. Basic & Clinical Pharmacology & Toxicology 116 (2015), 508–515.
168. Nelson, S.H., Steinsland, O.S., Wang, Y., Yallampalli, C., Dong, Y.L., Sanchez, J.M., Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circulation Research 87 (2000), 406–411.
169. Noorbakhsh, M., Kianpour, M., Nematbakhsh, M., Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN Obstetrics and Gynecology, 2013, 2013, 104213.
170. Noori, M., Donald, A.E., Angelakopoulou, A., Hingorani, A.D., Williams, D.J., Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 122 (2010), 478–487.
171. Novotny, S.R., Wallace, K., Heath, J., Moseley, J., Dhillon, P., Weimer, A., et al. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4 + T lymphocytes from placental ischemic rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 302 (2012), R1197–R1201.
172. Nugent, W.H., Mishra, N., Strauss, J.F. 3rd, Walsh, S.W., Matrix metalloproteinase 1 causes vasoconstriction and enhances vessel reactivity to angiotensin II via protease-activated receptor 1. Reproductive Sciences 23:4 (2016), 542–548.
173. Orie, N.N., Fry, C.H., Clapp, L.H., Evidence that inward rectifier K + channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism. Cardiovascular Research 69 (2006), 107–115.
174. Orshal, J.M., Khalil, R.A., Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 43 (2004), 434–444.
175. Ou, M., Dang, Y., Mazzuca, M.Q., Basile, R., Khalil, R.A., Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats. Journal of Cellular Physiology 229 (2014), 489–501.
176. Palei, A.C., Granger, J.P., Tanus-Santos, J.E., Matrix metalloproteinases as drug targets in preeclampsia. Current Drug Targets 14 (2013), 325–334.
177. Palei, A.C., Spradley, F.T., Warrington, J.P., George, E.M., Granger, J.P., Pathophysiology of hypertension in pre-eclampsia: A lesson in integrative physiology. Acta Physiologica (Oxford, England) 208 (2013), 224–233.
178. Palmer, K.R., Kaitu'u-Lino, T.J., Hastie, R., Hannan, N.J., Ye, L., Binder, N., et al. Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity. Hypertension 66 (2015), 1251–1259.
179. Papazoglou, D., Galazios, G., Koukourakis, M.I., Kontomanolis, E.N., Maltezos, E., Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstetricia et Gynecologica Scandinavica 83 (2004), 461–465.
180. Parra, M.C., Lees, C., Mann, G.E., Pearson, J.D., Nicolaides, K.H., Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia. American Journal of Obstetrics and Gynecology 184 (2001), 497–502.
181. Parrish, M.R., Ryan, M.J., Glover, P., Brewer, J., Ray, L., Dechend, R., et al. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gender Medicine 8 (2011), 184–188.
182. Peixoto, A.B., Araujo Junior, E., Ribeiro, J.U., Rodrigues, D.B., Castro, E.C., Caldas, T.M., et al. Evaluation of inflammatory mediators in the deciduas of pregnant women with pre-eclampsia/eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 29 (2016), 75–79.
183. Peracoli, M.T., Bannwart, C.F., Cristofalo, R., Borges, V.T., Costa, R.A., Witkin, S.S., et al. Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. American Journal of Reproductive Immunology 66 (2011), 460–467.
184. Pereira, R.D., De Long, N.E., Wang, R.C., Yazdi, F.T., Holloway, A.C., Raha, S., Angiogenesis in the placenta: The role of reactive oxygen species signaling. BioMed Research International, 2015, 2015, 814543.
185. Perez-Sepulveda, A., Torres, M.J., Khoury, M., Illanes, S.E., Innate immune system and preeclampsia. Frontiers in Immunology, 5, 2014, 244.
186. Pimentel, A.M., Pereira, N.R., Costa, C.A., Mann, G.E., Cordeiro, V.S., de Moura, R.S., et al. L-Arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia. Hypertension Research 36 (2013), 783–788.
187. Pinheiro, M.B., Gomes, K.B., Ronda, C.R., Guimaraes, G.G., Freitas, L.G., Teixeira-Carvalho, A., et al. Severe preeclampsia: Association of genes polymorphisms and maternal cytokines production in Brazilian population. Cytokine 71 (2015), 232–237.
188. Poston, L., McCarthy, A.L., Ritter, J.M., Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacology & Therapeutics 65 (1995), 215–239.
189. Raffetto, J.D., Ross, R.L., Khalil, R.A., Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K + channels: Relevance to varicose vein formation. Journal of Vascular Surgery 45 (2007), 373–380.
190. Rahardjo, B., Widjajanto, E., Sujuti, H., Keman, K., Different levels of IL-1alpha, IL-6, TNF-alpha, NF-kappaB and PPAR-gamma in monocyte cultures exposed by plasma preeclampsia and normotensive pregnancy. Pregnancy Hypertension 4 (2014), 187–193.
191. Rahgozar, S., Amirian, T., Qi, M., Shahshahan, Z., Entezar, E.G.M., Ghasemi Tehrani, H., et al. Improved assay for quantifying a redox form of angiotensinogen as a biomarker for pre-eclampsia: A case-control study. PLoS One, 10, 2015, e0135905.
192. Rahimzadeh, M., Norouzian, M., Arabpour, F., Naderi, N., Regulatory T-cells and preeclampsia: An overview of literature. Expert Review of Clinical Immunology 12:2 (2016), 209–227.
193. Ramesar, S.V., Mackraj, I., Gathiram, P., Moodley, J., Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats. European Journal of Obstetrics, Gynecology, and Reproductive Biology 157 (2011), 136–140.
194. Ramma, W., Buhimschi, I.A., Zhao, G., Dulay, A.T., Nayeri, U.A., Buhimschi, C.S., et al. The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis 15 (2012), 333–340.
195. Regal, J.F., Lillegard, K.E., Bauer, A.J., Elmquist, B.J., Loeks-Johnson, A.C., Gilbert, J.S., Neutrophil depletion attenuates placental ischemia-induced hypertension in the rat. PLoS One, 10, 2015, e0132063.
196. Reslan, O.M., Khalil, R.A., Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovascular & Hematological Agents in Medicinal Chemistry 8 (2010), 204–226.
197. Rios, D.R., Alpoim, P.N., Godoi, L.C., Perucci, L.O., de Sousa, L.P., Gomes, K.B., et al. Increased levels of sENG and sVCAM-1 and decreased levels of VEGF in severe preeclampsia. American Journal of Hypertension, 2015 pii: hpv170. [Epub ahead of print].
198. Roberts, J.M., Endothelial dysfunction in preeclampsia. Seminars in Reproductive Endocrinology 16 (1998), 5–15.
199. Roberts, J.M., Escudero, C., The placenta in preeclampsia. Pregnancy Hypertension 2 (2012), 72–83.
200. Romero, R., Nien, J.K., Espinoza, J., Todem, D., Fu, W., Chung, H., et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. The Journal of Maternal-Fetal & Neonatal Medicine 21 (2008), 9–23.
201. Rosenberg, T.J., Garbers, S., Lipkind, H., Chiasson, M.A., Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: Differences among 4 racial/ethnic groups. American Journal of Public Health 95 (2005), 1545–1551.
202. Royle, C., Lim, S., Xu, B., Tooher, J., Ogle, R., Hennessy, A., Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants. Cytokine 47 (2009), 56–60.
203. Sakashita, T., Higashi, Y., Soga, J., Miyoshi, H., Kudo, Y., Circulating endothelial progenitor cells and placental abruption in women with preeclampsia. Pregnancy Hypertension 4 (2014), 203–208.
204. Sanchez-Aranguren, L.C., Prada, C.E., Riano-Medina, C.E., Lopez, M., Endothelial dysfunction and preeclampsia: Role of oxidative stress. Frontiers in Physiology, 5, 2014, 372.
205. Sandrim, V.C., Palei, A.C., Sertorio, J.T., Cavalli, R.C., Duarte, G., Tanus-Santos, J.E., Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Molecular Human Reproduction 16 (2010), 506–510.
206. Santillan, M.K., Santillan, D.A., Scroggins, S.M., Min, J.Y., Sandgren, J.A., Pearson, N.A., et al. Vasopressin in preeclampsia: A novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension 64 (2014), 852–859.
207. Sasaki, Y., Darmochwal-Kolarz, D., Suzuki, D., Sakai, M., Ito, M., Shima, T., et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clinical and Experimental Immunology 149 (2007), 139–145.
208. Say, L., Chou, D., Gemmill, A., Tuncalp, O., Moller, A.B., Daniels, J., et al. Global causes of maternal death: A WHO systematic analysis. Lancet Global Health 2 (2014), e323–e333.
209. Scalera, F., Schlembach, D., Beinder, E., Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology 99 (2001), 172–178.
210. Schiessl, B., Strasburger, C., Bidlingmaier, M., Mylonas, I., Jeschke, U., Kainer, F., et al. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Archives of Gynecology and Obstetrics 274 (2006), 150–154.
211. Schramm, A.M., Clowse, M.E., Aspirin for prevention of preeclampsia in lupus pregnancy. Autoimmune Diseases, 2014, 2014, 920467.
212. Serin, I.S., Ozcelik, B., Basbug, M., Kilic, H., Okur, D., Erez, R., Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 100 (2002), 143–145.
213. Shaamash, A.H., Elsnosy, E.D., Makhlouf, A.M., Zakhari, M.M., Ibrahim, O.A., EL-dien, H.M., Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. International Journal of Gynaecology and Obstetrics 68 (2000), 207–214.
214. Shah, D.A., Khalil, R.A., Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochemical Pharmacology 95 (2015), 211–226.
215. Shen, B.Q., Lee, D.Y., Zioncheck, T.F., Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. The Journal of Biological Chemistry 274 (1999), 33057–33063.
216. Shesely, E.G., Gilbert, C., Granderson, G., Carretero, C.D., Carretero, O.A., Beierwaltes, W.H., Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy. American Journal of Obstetrics and Gynecology 185 (2001), 1198–1203.
217. Shimokawa, H., Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflügers Archiv 459 (2010), 915–922.
218. Siddiqui, A.H., Irani, R.A., Zhang, W., Wang, W., Blackwell, S.C., Kellems, R.E., et al. Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension 61 (2013), 472–479.
219. Sierra-Laguado, J., Garcia, R.G., Lopez-Jaramillo, P., Flow-mediated dilatation of the brachial artery in pregnancy. International Journal of Gynaecology and Obstetrics 93 (2006), 60–61.
220. Siljee, J.E., Wortelboer, E.J., Koster, M.P., Imholz, S., Rodenburg, W., Visser, G.H., et al. Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays. Prenatal Diagnosis 33 (2013), 1183–1188.
221. Smith-Jackson, K., Hentschke, M.R., Poli-de-Figueiredo, C.E., Pinheiro da Costa, B.E., Kurlak, L.O., Broughton Pipkin, F., et al. Placental expression of eNOS, iNOS and the major protein components of caveolae in women with pre-eclampsia. Placenta 36 (2015), 607–610.
222. Sones, J.L., Lob, H.E., Isroff, C.E., Davisson, R.L., Role of decidual natural killer cells, interleukin-15, and interferon-gamma in placental development and preeclampsia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 307 (2014), R490–R492.
223. Spradley, F.T., Palei, A.C., Granger, J.P., Increased risk for the development of preeclampsia in obese pregnancies: Weighing in on the mechanisms. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 309 (2015), R1326–R1343.
224. Stillman, I.E., Karumanchi, S.A., The glomerular injury of preeclampsia. Journal of the American Society of Nephrology 18 (2007), 2281–2284.
225. Sunderland, N.S., Thomson, S.E., Heffernan, S.J., Lim, S., Thompson, J., Ogle, R., et al. Tumor necrosis factor alpha induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine 56 (2011), 192–199.
226. Tal, R., The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biology of Reproduction, 87, 2012, 134.
227. Tanbe, A.F., Khalil, R.A., Circulating and vascular bioactive factors during hypertension in pregnancy. Current Bioactive Compounds 6 (2010), 60–75.
228. Taylor, R.N., Varma, M., Teng, N.N., Roberts, J.M., Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. The Journal of Clinical Endocrinology and Metabolism 71 (1990), 1675–1677.
229. Thadhani, R., Hagmann, H., Schaarschmidt, W., Roth, B., Cingoez, T., Karumanchi, S.A., et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. Journal of the American Society of Nephrology: JASN 27:3 (2016), 903–913.
230. Thornburg, K.L., Jacobson, S.L., Giraud, G.D., Morton, M.J., Hemodynamic changes in pregnancy. Seminars in Perinatology 24 (2000), 11–14.
231. Trifonova, E.A., Gabidulina, T.V., Ershov, N.I., Serebrova, V.N., Vorozhishcheva, A.Y., Stepanov, V.A., Analysis of the placental tissue transcriptome of normal and preeclampsia complicated pregnancies. Acta Naturae 6 (2014), 71–83.
232. Trowsdale, J., Moffett, A., NK receptor interactions with MHC class I molecules in pregnancy. Seminars in Immunology 20 (2008), 317–320.
233. Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J.F., Pignon, M.R., Noel, A., et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. The Journal of Clinical Endocrinology and Metabolism 88 (2003), 5555–5563.
234. Tsukimori, K., Fukushima, K., Tsushima, A., Nakano, H., Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies. Hypertension 46 (2005), 696–700.
235. Turpin, C.A., Sakyi, S.A., Owiredu, W.K., Ephraim, R.K., Anto, E.O., Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Pregnancy and Childbirth, 15, 2015, 189.
236. Tuzcu, Z.B., Asicioglu, E., Sunbul, M., Ozben, B., Arikan, H., Koc, M., Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women. American Journal of Obstetrics and Gynecology 213:533 (2015), e531–e537.
237. Valdes, G., Kaufmann, P., Corthorn, J., Erices, R., Brosnihan, K.B., Joyner-Grantham, J., Vasodilator factors in the systemic and local adaptations to pregnancy. Reproductive Biology and Endocrinology, 7, 2009, 79.
238. van der Heijden, O.W., Essers, Y.P., Fazzi, G., Peeters, L.L., De Mey, J.G., van Eys, G.J., Uterine artery remodeling and reproductive performance are impaired in endothelial nitric oxide synthase-deficient mice. Biology of Reproduction 72 (2005), 1161–1168.
239. van Dijk, M., Oudejans, C.B., STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation. Journal of Pregnancy, 2011, 2011, 521826.
240. van Dijk, M., Oudejans, C., (Epi)genetics of pregnancy-associated diseases. Frontiers in Genetics, 4, 2013, 180.
241. VanWijk, M.J., Kublickiene, K., Boer, K., VanBavel, E., Vascular function in preeclampsia. Cardiovascular Research 47 (2000), 38–48.
242. Velloso, E.P., Pimentel, R.L., Braga, J.F., Cabral, A.C., Reis, Z.S., Bader, M., et al. Identification of a novel agonist-like autoantibody in preeclamptic patients. American Journal of Hypertension 29:3 (2015), 405–412.
243. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 12 (2006), 642–649.
244. Verdonk, K., Saleh, L., Lankhorst, S., Smilde, J.E., van Ingen, M.M., Garrelds, I.M., et al. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression. Hypertension 65 (2015), 1316–1323.
245. Verlohren, S., Niehoff, M., Hering, L., Geusens, N., Herse, F., Tintu, A.N., et al. Uterine vascular function in a transgenic preeclampsia rat model. Hypertension 51 (2008), 547–553.
246. von Dadelszen, P., Dwinnell, S., Magee, L.A., Carleton, B.C., Gruslin, A., Lee, B., et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 118 (2011), 624–628.
247. Wallace, K., Richards, S., Dhillon, P., Weimer, A., Edholm, E.S., Bengten, E., et al. CD4 + T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57 (2011), 949–955.
248. Walsh, S.W., Eicosanoids in preeclampsia. Prostaglandins, Leukotrienes, and Essential Fatty Acids 70 (2004), 223–232.
249. Wang, K., Ahmad, S., Cai, M., Rennie, J., Fujisawa, T., Crispi, F., et al. Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation 127 (2013), 2514–2522.
250. Wang, W., Parchim, N.F., Iriyama, T., Luo, R., Zhao, C., Liu, C., et al. Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia. Hypertension 63 (2014), 595–606.
251. Wang, Y., Walsh, S.W., Kay, H.H., Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. American Journal of Obstetrics and Gynecology 167 (1992), 946–949.
252. Wang, L., Yang, T., Ding, Y., Zhong, Y., Yu, L., Peng, M., Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia. Endocrine 48 (2015), 299–308.
253. Wei, Y.M., Yang, H.X., Zhu, W.W., Liu, X.Y., Meng, W.Y., Wang, Y.Q., et al. Risk of adverse pregnancy outcomes stratified for pre-pregnancy body mass index. The Journal of Maternal-Fetal & Neonatal Medicine, 2015, 1–5 [Epub ahead of print].
254. Weigand, L., Sylvester, J.T., Shimoda, L.A., Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats. American Journal of Physiology. Lung Cellular and Molecular Physiology 290 (2006), L284–L290.
255. Weiner, C.P., Thompson, L.P., Liu, K.Z., Herrig, J.E., Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. American Journal of Obstetrics and Gynecology 166 (1992), 1171–1178 discussion 1179–1181.
256. Williams, D.J., Vallance, P.J., Neild, G.H., Spencer, J.A., Imms, F.J., Nitric oxide-mediated vasodilation in human pregnancy. The American Journal of Physiology 272 (1997), H748–H752.
257. Xia, Y., Ramin, S.M., Kellems, R.E., Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50 (2007), 269–275.
258. Yang, J., Li, L., Shang, J.Y., Cai, L., Song, L., Zhang, S.L., et al. Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia. Journal of Hypertension 33 (2015), 1046–1056.
259. Yang, X., Wang, F., Lau, W.B., Zhang, S., Liu, H., Ma, X.L., Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor. Cardiovascular Toxicology 14 (2014), 21–29.
260. Yi, F.X., Boeldt, D.S., Gifford, S.M., Sullivan, J.A., Grummer, M.A., Magness, R.R., et al. Pregnancy enhances sustained Ca2 + bursts and endothelial nitric oxide synthase activation in ovine uterine artery endothelial cells through increased connexin 43 function. Biology of Reproduction 82 (2010), 66–75.
261. Yinon, Y., Ben Meir, E., Margolis, L., Lipitz, S., Schiff, E., Mazaki-Tovi, S., et al. Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor. Placenta 36 (2015), 121–124.
262. Yinon, Y., Nevo, O., Xu, J., Many, A., Rolfo, A., Todros, T., et al. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: Hypoxic regulation via transforming growth factor-beta 3. The American Journal of Pathology 172 (2008), 77–85.
263. Yoshida, A., Nakao, S., Kobayashi, M., Kobayashi, H., Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 36 (2000), 400–404.
264. Yu, Y., Wang, L., Liu, T., Guan, H., MicroRNA-204 suppresses trophoblast-like cell invasion by targeting matrix metalloproteinase-9. Biochemical and Biophysical Research Communications 463 (2015), 285–291.
265. Yuksel, M.A., Tuten, A., Oncul, M., Acikgoz, A.S., Temel Yuksel, I., Toprak, M.S., et al. Serum endocan concentration in women with pre-eclampsia. Archives of Gynecology and Obstetrics 292 (2015), 69–73.
266. Zarate, A., Saucedo, R., Valencia, J., Manuel, L., Hernandez, M., Early disturbed placental ischemia and hypoxia creates immune alteration and vascular disorder causing preeclampsia. Archives of Medical Research 45 (2014), 519–524.
267. Zawiejska, A., Wender-Ozegowska, E., Iciek, R., Brazert, J., Concentrations of endothelial nitric oxide synthase, angiotensin-converting enzyme, vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive disorders. Journal of Human Hypertension 28 (2014), 670–676.
268. Zhao, S., Gu, Y., Lewis, D.F., Wang, Y., Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies. Placenta 29 (2008), 81–88.
269. Zhao, Y., Zheng, Y.F., Luo, Q.Q., Yan, T., Liu, X.X., Han, L., et al. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: A possible therapeutic approach to preeclampsia. Placenta 35 (2014), 476–482.
270. Zhou, C.C., Zhang, Y., Irani, R.A., Zhang, H., Mi, T., Popek, E.J., et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nature Medicine 14 (2008), 855–862.
271. Zhu, X., Wu, S., Dahut, W.L., Parikh, C.R., Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis. American Journal of Kidney Diseases 49 (2007), 186–193.
272. Zhu, J., Zhong, M., Pang, Z., Yu, Y., Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction. Early Human Development 90 (2014), 657–664.